Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation. | Mol Cell Proteomics | 2022 | 35594991 | PubTator, text mining | PubMed |
| DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production. | Mol Cell | 2022 | 35594857 | PubTator, text mining | PubMed |
| Proteomic Analysis of the Intestinal Resistance to Thyroid Hormone Mouse Model With Thyroid Hormone Receptor Alpha Mutations. | Front Endocrinol (Lausanne) | 2022 | 35574030 | PubTator, text mining | PubMed |
| The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes. | Cells | 2022 | 35563886 | PubTator, text mining | PubMed |
| Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. | Blood Adv | 2022 | 35561310 | PubTator, text mining | PubMed |
| Fundamental immune-oncogenicity trade-offs define driver mutation fitness. | Nature | 2022 | 35545680 | PubTator, text mining | PubMed |
| The genomic and transcriptional landscape of primary central nervous system lymphoma. | Nat Commun | 2022 | 35538064 | PubTator, text mining | PubMed |
| Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. | Oncoimmunology | 2022 | 35529675 | PubTator, text mining | PubMed |
| Omics of endothelial cell dysfunction in sepsis. | Vasc Biol | 2022 | 35515704 | PubTator, text mining | PubMed |
| Shared genetic links between frontotemporal dementia and psychiatric disorders. | BMC Med | 2022 | 35509074 | PubTator, text mining | PubMed |
| CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity. | JCI Insight | 2022 | 35503656 | PubTator, text mining | PubMed |
| Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer. | J Clin Invest | 2022 | 35499080 | PubTator, text mining | PubMed |
| Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer. | Front Cell Dev Biol | 2022 | 35493099 | PubTator, text mining | PubMed |
| Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China. | Int J Immunogenet | 2022 | 35485366 | PubTator, text mining | PubMed |
| Transcriptome alterations in spermatogonial stem cells exposed to bisphenol A. | Anim Cells Syst (Seoul) | 2022 | 35479511 | PubTator, text mining | PubMed |
| Proteomic networks associated with tumor-educated macrophage polarization and cytotoxicity potentiated by heat-killed tuberculosis. | Sci Rep | 2022 | 35477732 | PubTator, text mining | PubMed |
| In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis. | Evid Based Complement Alternat Med | 2022 | 35463077 | PubTator, text mining | PubMed |
| Microarray dataset supporting a role for ATF4 in isoginkgetin-induced gene expression in HCT116 cells. | Data Brief | 2022 | 35463055 | PubTator, text mining | PubMed |
| Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors. | Micromachines (Basel) | 2022 | 35457828 | PubTator, text mining | PubMed |
| Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies. | Cells | 2022 | 35456007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=26